This week, the Securities and Exchange Commission (the “SEC”) published its semiannual Regulatory Flexibility Agenda (“Reg Flex Agenda”), detailing its short-term and long-term rulemaking priorities for the year. The SEC is not bound to meet the target deadlines outlined in its agendas.

There are no surprises, and the plurality of updates center around: 

  • Crypto assets: The potential creation of safe harbors and exemptions to facilitate transactions and trading, as well as rules related to issuances under the Securities Act, broker-dealer and market regulation, fund advisor and investment company custody rules, and extending the role of transfer agents to cover digital assets and the use of distributed ledger technology.
  • Facilitating public registration and reporting, including streamlining disclosure, reducing compliance burdens of shelf registration, and expanding the benefits available to emerging growth companies and simplifying the accelerated filer framework.
  • Facilitating private markets, by broadening the Rule 144 safe harbor for resales of control and restricted securities, and by broadening existing Securities Act exemptions. We anticipate that any changes, including potential watering down of the definition of “accredited investor,” will be balanced against the SEC’s focus on increasing the use of the public markets. 
  • Re-examining some rules that have received criticism, such as Form N-PORT and Consolidated Audit Trail (CAT), and Rule 14a-8, the shareholder proposal rule.   

Overall, the Reg Flex Agenda is consistent with the current Commission’s stated goals to reduce regulatory burdens, including on public companies or companies looking to go public, and to facilitate capital formation.

The SEC Spring 2025 Regulatory Agenda is available here.

Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of Frank Zarb Frank Zarb

Frank Zarb is a partner in our Corporate Department and a member of the Capital Markets Group, where he concentrates his practice on equity finance and a wide range of regulatory matters under U.S. federal securities laws.

He counsels public and private companies…

Frank Zarb is a partner in our Corporate Department and a member of the Capital Markets Group, where he concentrates his practice on equity finance and a wide range of regulatory matters under U.S. federal securities laws.

He counsels public and private companies, hedge funds and family offices, and market intermediaries and other financial institutions on a wide range of transactional and securities regulatory compliance matters including:

  • Equity investments and dispositions in public and private companies
  • Public company registration, disclosures and preparation of periodic reports
  • Tender offers, equity lines, proxy contests, SPACs, and other highly regulated transactions
  • Regulation M, Regulation SHO, Forms 13F and 13H, insider trading and other trading issues
  • Corporate governance and stock exchange listing standards
  • Federal and state proxy requirements as well as shareholder proposals and communications
  • Regulation of financial intermediaries, including trading of public and private equity, and complex and novel trading structures
  • Advocating with the SEC on behalf of a market intermediary related to back-office processing matters.

Frank’s practice is both domestic and international, beginning with his experience in senior positions with the Securities and Exchange Commission. As a member of the staff of the SEC’s Office of International Corporate Finance, Frank advised U.S. companies seeking to do business in the EU, Asia and the Middle East, as well as companies from those regions doing business in the U.S., or otherwise seeking to comply with the U.S. securities laws.  In the Office of Chief Counsel, he focused on federal proxy rules, and supervised a team of staff members that provided guidance in the course of proxy season.

Prior to joining the Firm, Frank was deputy general counsel/chief securities counsel for Bristol Myers Squibb Co. in a new position required by the SEC. Prior to joining Bristol-Myers, Frank was a corporate partner with Morgan, Lewis & Brockius.

Social Responsibility

Frank is a Trustee of the Gerald R. Ford Presidential Foundation, and he provides significant pro bono assistance to non-profit social service institutions in the Washington, D.C. area.

Photo of Louis Rambo Louis Rambo

Louis Rambo is a partner in the Corporate Department and a member of the Capital Markets Group. He focuses his practice on counseling public companies and their boards of directors on corporate governance, capital markets transactions, mergers and acquisitions, securities regulation, disclosure and…

Louis Rambo is a partner in the Corporate Department and a member of the Capital Markets Group. He focuses his practice on counseling public companies and their boards of directors on corporate governance, capital markets transactions, mergers and acquisitions, securities regulation, disclosure and shareholder activism. Drawing on his previous tenure with the Securities and Exchange Commission in the Division of Corporation Finance, Louis partners with clients on capital raising, including underwritten equity transactions, at-the-market offerings and high-yield and investment grade debt offerings, as well as on structuring M&A transactions, spin-offs, tender offers and going private transactions. He advises public companies on developing governance and disclosure matters, including director independence, compensation, insider trading issues, shareholder proposals and stockholder meetings, and advises on shareholder activism and takeover defense.

Louis also regularly advises hedge funds, private equity funds, family offices, private companies and other financial institutions on a wide range of transactional and securities regulatory compliance matters, including capital raising, PIPEs and secondary transactions, novel and complex beneficial ownership issues arising under the federal securities laws, derivative transactions, insider trading issues and policies and compliance programs.

Louis previously served as an attorney with the SEC in the Division of Corporation Finance. While at the SEC, Louis worked on a number of transactional and securities compliance matters.

Photo of Simon J. Wood Simon J. Wood

Simon J. Wood is an associate in the Corporate Department and a member of the Capital Markets Group. His practice focuses on IPOs, SPAC transactions, and Section 13 and Section 16 filings. Since joining Proskauer, Simon has worked on a variety of SPAC…

Simon J. Wood is an associate in the Corporate Department and a member of the Capital Markets Group. His practice focuses on IPOs, SPAC transactions, and Section 13 and Section 16 filings. Since joining Proskauer, Simon has worked on a variety of SPAC transactions including the IPOs of Kimbell Tiger Acquisition Corp., Juniper II Corp., Israel Acquisitions Corp, and more. He is currently part of the Proskauer team advising Goal Acquisitions Corp. in its business combination with Digital Virgo Group.

Simon earned his J.D. degree from Harvard Law School, where he worked on the Journal of Law and Technology and was part of the Cyberlaw Clinic.

Prior to joining Proskauer, Simon was an associate in the New York offices of Kirkland & Ellis.